Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe five most commonly reported Mounjaro side effects are nausea, vomiting, diarrhoea, constipation and indigestion — together they account for the majority of reports in clinical trials. Most people experience them around a dose start or increase, and they generally ease within days to two weeks. That pattern matters, because it shapes one of the first real decisions you'll face on tirzepatide: whether a side effect is something to ride out, something to manage with your prescriber, or something that needs medical attention today. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Nausea tops the list. In the SURMOUNT-1 trial (which followed thousands of adults taking tirzepatide for 72 weeks) nausea was the most commonly reported complaint, particularly in the early weeks of treatment and after each dose step up. It rarely hits hard all day; most people describe it as a queasy hour or two after the injection, often improving once the body has had a few days to adjust.
Vomiting and diarrhoea sit just behind nausea in frequency. They follow a similar pattern: more likely when treatment first starts or the dose changes, usually settling on their own. Constipation is the counterpart that sometimes surprises people, Mounjaro slows gastric emptying, which can slow movement further along the gut too. Staying well hydrated and keeping fibre in your diet helps. Indigestion and reflux round out the five; some people find eating smaller meals reduces them noticeably.
The NHS patient information page for tirzepatide sets out these common effects clearly, and it is worth reading before your first pen. Our side-effect overview at Mounjaro side effects goes deeper into each one if you want more detail.
This is the decision most people find genuinely hard. The honest answer is that mild, transient nausea after a dose increase is expected and usually not a clinical emergency. But there are signals that shift the calculation.
Severe, persistent stomach pain (especially pain that spreads toward the back, with or without vomiting) needs urgent medical review. That is the key warning sign for acute pancreatitis, which is an infrequent but serious effect associated with GLP-1 medicines. In January 2026 the MHRA published a Drug Safety Update specifically highlighting pancreatitis as a known risk, and their guidance is clear: don't wait and see with that type of pain.
Other effects that warrant contacting a healthcare professional rather than waiting: signs of gallbladder trouble (pain in the upper right abdomen, fever, yellowing skin), any allergic reaction (swelling of the face or throat, difficulty breathing), and significant dehydration from repeated vomiting or diarrhoea, particularly if you can't keep fluids down. If you're worried about anything at all, our team is available seven days a week via our contact page.
There is a separate question about side effects in specific situations, how side effects present in people with PCOS, for example, is something our prescribers are asked about regularly.
The side effects of Mounjaro at 5mg (the first step up from the 2.5mg starter dose) are similar in type to what people experience at the beginning of treatment, just sometimes a little more pronounced. The 2.5mg dose exists precisely to let your system adjust before the dose increases; 5mg is where some people first notice that the GI effects have more bite. That's not unusual, and it doesn't necessarily mean you'll feel the same at 7.5mg or beyond.
People who find 5mg particularly difficult sometimes ask whether skipping the increase and staying at 2.5mg is an option. That is exactly the kind of titration question a prescriber should guide, not something to decide alone. If you're collecting a repeat and wondering what's typical for people further into treatment, the experience of people who report no side effects is worth reading alongside this page.
Side effects in men can present slightly differently in terms of which symptoms are most prominent; our page on Mounjaro side effects in men covers that angle specifically. And if you've heard from someone whose experience was very different from what you expected, the broader picture of what to expect may help put your own situation in context.
One practical note worth flagging: if you're planning a holiday or know you'll be away from your usual routine, discuss timing with your prescriber before a dose change. Starting or stepping up around travel (or even just around a busy week) can make it harder to tell whether symptoms are from the medicine or the disruption. It's a small thing, but patients who flag it ahead of time tend to find the adjustment smoother.
The MHRA's Yellow Card scheme exists so that patients and clinicians can flag suspected side effects, including unexpected ones. You can report at yellowcard.mhra.gov.uk, it takes a few minutes and contributes to ongoing medicine safety monitoring. You don't need to be certain a symptom is caused by the medicine to report it; suspicion is enough.
At nume, every repeat order is reviewed by a prescriber before it is approved. If your experience doesn't match what's described here, or something feels off, that review is the right moment to raise it. Our prescribers also discuss side effect likelihood and management as part of the initial consultation, it's one of the things covered before any treatment is confirmed. If you'd like to understand more about what a consultation involves, our treatment page sets out the process. Or if you want to read about the wider Mounjaro treatment before deciding anything, that's a good place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.